Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype

Vaccine

Volumn 30, Issue 42, 2012, Pages 6088-6092

  Chen, Ming ^a,b   Wang, Rui ^b   Li, Li Ping ^b   Liang, Wan Wen ^b   Li, Jian ^a   Huang, Yan ^c   Lei, Ai Ying ^b   Huang, Wei Yi ^a   Gan, Xi ^b  

^a GUANGXI UNIVERSITY   (China)

^b Guangxi Institute of Fisheries   (China)

^c GUANGXI CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

PFGE; Serotype; Streptococcus agalactiae; Tilapia; Vaccine candidate strain

Indexed keywords

BACTERIAL VACCINE;

ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CHINA; CONTROLLED STUDY; DRUG SCREENING; GENOTYPE; GROUP B STREPTOCOCCAL INFECTION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SURVIVAL; TILAPIA;

ANIMALS; BACTERIAL VACCINES; CROSS PROTECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; FISH DISEASES; GENOTYPE; STREPTOCOCCUS AGALACTIAE; TILAPIA; VACCINES, COMBINED;

EID: 84865548210     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.044     Document Type: Article

References (30)

1. Mian G.F., Godoy D.T., Leal C.A., Yuhara T.Y., Costa G.M., Figueiredo H.C. Aspects of the natural history and virulence of S. agalactiae infection in Nile tilapia. Vet Microbiol 2009, 136(1-2):180-183.
2. Pridgeon J.W., Aksoy M., Klesius P.H., Li Y., Mu X., Srivastava K., et al. Identification and expression profiles of multiple genes in Nile tilapia in response to bacterial infections. Vet Immunol Immunopathol 2011, 144(1-2):111-119.
3. Ye X., Li J., Lu M., Deng G., Jiang X., Tian Y., et al. Identification and molecular typing of Streptococcus agalactiae isolated from pond-cultured tilapia in China. Fish Sci 2011, 77:623-632.
4. Li J.R., Lu H.X., Zhu J.L., Wang Y.B., Li X.P. Aquatic products processing industry in China: challenges and outlook. Trends Food Sci Technol 2009, 20:73-77.
5. Chai J.Q., Ding Q.L., Wang Z.L., Song J.Y. Isolation and identification of streptococcal bacteria isolated from tilapia. Chin J Prevent Vet Med 2002, 24:18-20.
6. Chen M., Li L.P., Wang R., Liang W.W., Huang Y., Li J., et al. PCR detection and PFGE genotype analyses of streptococcal clinical isolates from tilapia in China. Vet Microbiol 2012, 10.1016/j.vetmic.2012.04.035.
7. Darwish A.M. Laboratory efficacy of florfenicol against Streptococcus iniae infection in sunshine bass. J Aquat Anim Health 2007, 19:1-7.
8. Eldar A., Shapiro O., Bejerano Y., Bercovier H. Vaccination with whole-cell vaccine and bacterial protein extract protects tilapia against Streptococcus difficile meningoencephalitis. Vaccine 1995, 13(9):867-870.
9. Klesius P.H., Shoemaker C.A., Evans J.J. Efficacy of a killed Streptococcus iniae vaccine in tilapia (Oreochromis niloticus). Bull Eur Assoc Fish Pathol 1999, 19:39-41.
10. Pridgeon J.W., Klesius P.H. Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus). Vaccine 2011, 29(35):5986-5993.
11. Evans J.J., Klesius P.H., Shoemaker C.A. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration. Vaccine 2004, 22(27-28):3769-3773.
12. Pretto-Giordano L.G., Müller E.E., Klesius P., Silva V.G.D. Efficacy of an experimentally inactivated Streptococcus agalactiae vaccine in Nile tilapia (Oreochromis niloticus) reared in Brazil. Aquac Res 2010, 14(10):1539-1544.
13. Sun Y., Hu Y.H., Liu C.S., Sun L. Construction and analysis of an experimental Streptococcus iniae DNA vaccine. Vaccine 2010, 28(23):3905-3912.
14. Dumrongphol Y., Hirota T., Kondo H., Aoki T., Hirono I. Identification of novel genes in Japanese flounder (Paralichthys olivaceus) head kidney up-regulated after vaccination with Streptococcus iniae formalin-killed cells. Fish Shellfish Immunol 2009, 26(1):197-200.
15. Shin G.W., Palaksha K.J., Kim Y.R., Nho S.W., Kim S., Heo G.J., et al. Application of immunoproteomics in developing a Streptococcus iniae vaccine for olive flounder (Paralichthys olivaceus). J Chromatogr B: Analyt Technol Biomed Life Sci 2007, 849(1-2):315-322.
16. Pereira U.P., Mian G.F., Oliveira I.C., Benchetrit L.C., Costa G.M., Figueiredo H.C. Genotyping of Streptococcus agalactiae strains isolated from fish, human and cattle and their virulence potential in Nile tilapia. Vet Microbiol 2010, 140(1-2):186-192.
17. Naraid S., Fanrong K., Gwendolyn L.G., Danny K., Kidchakan S. Occurrence of rare genotypes of Streptococcus agalactiae in cultured red tilapia Oreochromis sp. and Nile tilapia O. niloticus in Thailand-relationship to human isolates?. Aquaculture 2008, 284:35-40.
18. Vandamme P., Devriese L.A., Pot B., Kersters K., Melin P. Streptococcus difficile is a nonhemolytic group B, type Ib Streptococcus. Int J Syst Bacteriol 1997, 47:81-85.
19. Evans J.J., Bohnsack J.F., Klesius P.H., Whiting A.A., Garcia J.C., Shoemaker C.A., et al. Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. J Med Microbiol 2008, 57:1369-1376.
20. Olivares-Fuster O., Klesius P.H., Evans J., Arias C.R. Molecular typing of Streptococcus agalactiae isolates from fish. J Fish Dis 2008, 31(4):277-283.
21. Baeck G.W., Kim J.H., Gomez D.K., Park S.C. Isolation and characterization of Streptococcus sp. from diseased flounder (Paralichthys olivaceus) in Jeju Island. J Vet Sci 2006, 7:53-58.
22. Claire P., Asmaa T., Helene R.P., Annick B., Nicole T., Josette R., et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007, 45(6):1985-1988.
23. Johri A.K., Paoletti L.C., Glaser P., Dua M., Sharma P.K., Grandi G., et al. B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006, 4(12):932-942.
24. Schrag S.J., Zywicki S., Farley M.M., Reingold A.L., Harrison L.H., Lefkowitz L.B., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000, 342(1):15-20.
25. Levine E.M., Ghai V., Barton J.J., Strom C.M. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999, 7(4):210-213.
26. Paoletti L.C., Pinel J., Johnson K.D., Reinap B., Ross R.A., Kasper D.L. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII. J Infect Dis 1999, 180(3):892-895.
27. Tettelin H., Masignani V., Cieslewicz M.J., Donati C., Medini D., Ward N.L., et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial pan-genome. Proc Natl Acad Sci USA 2005, 102(39):13950-13955.
28. Maione D., Margarit I., Rinaudo C.D., Masignani V., Mora M., Scarselli M., et al. Identification of a universal group B streptococcus vaccine by multiple genome screen. Science 2005, 309:148-150.
29. Skjaervold N.K., Bergh K., Bevanger L. Distribution of PFGE types of invasive Norwegian group B streptococci in relation to serotypes. Indian J Med Res 2004, 119:201-204.
30. Pillai P., Srinivasan U., Zhang L., Borchardt S.M., Debusscher J., Marrs C.F., et al. Streptococcus agalactiae pulsed-field gel electrophoresis patterns cross capsular types. Epidemiol Infect 2009, 137:1420-1425.